Multiple sclerosis (MS) is a demyelinating disease of the CNS involving T cell targeting of myelin antigens. During pregnancy, women with MS experience decreased relapses followed by a post partum disease flare. Using murine experimental autoimmune encephalomyelitis, we recapitulate pregnancy findings in both relapsing and progressive models. Pregnant mice produced less TNF-α, IL-17 and exhibited reduced CNS pathology relative to non-pregnant controls. Microparticles, called exosomes, shed into the blood during pregnancy were isolated and found to significantly suppress T cell activation relative to those from nonpregnant controls. These results demonstrate the immunosuppressive potential of pregnancy and serumderived pregnancy exosomes.
Introduction
Multiple sclerosis (MS) is a chronic demyelinating disease of the CNS thought to involve an autoimmune response directed against myelin antigens (Wingerchuk et al., 2001) . MS typically presents during the reproductive years and shows a female preponderance (3:1). Females typically demonstrate a relapsing-remitting (RRMS) clinical course (Whitacre et al., 1999) , while males tend to have a more rapidly progressive form. Importantly, one of the most profound clinically suppressed periods in MS is observed during late pregnancy. This phenomenon has been observed in other immune-mediated disease states such as rheumatoid arthritis, and is thought to represent immune changes occurring to maintain the fetal allograft (Chaouat, 1987) . Multiple studies have reported a general reduction in MS clinical disease activity during pregnancy (Birk et al., 1990; Bernardi et al., 1991; Davis and Maslow, 1992; Runmarker and Andersen, 1995; Damek and Shuster, 1997) . Confavreux et al. (1998) conducted a series of large-scale human studies in women with RRMS who subsequently became pregnant. Results showed a pronounced decrease in the rate of relapse during late pregnancy followed by a post partum flare in disease. Recently, animal models have been used to identify specific pregnancy factors (Langer-Gould et al., 2002; McClain et al., 2007) .
Experimental autoimmune encephalomyelitis (EAE) is a commonly used animal model for MS, sharing clinical, histopathologic and immunologic similarities with the human disease (Paterson, 1988) . EAE is inducible in susceptible rodent strains by immunization with myelin proteins or peptides such as myelin basic protein, proteolipid protein (PLP), or myelin oligodendrocyte glycoprotein (MOG). Susceptibility to disease induced by the various peptides is strain dependent and, as with human autoimmune disease, there is a demonstrable sex dimorphism noted within mouse stains (Encinas et al., 1996; Papenfuss et al., 2004) . For example, SJL female, but not male mice immunized with the immunodominant epitope of PLP show a relapsing-remitting course of EAE that is similar to the clinical course observed in patients with RRMS. Conversely, C57Bl/6 males and females immunized with MOG peptides both exhibit a similar clinical course reminiscent of primary progressive MS (Papenfuss et al., 2004) . Targeting the variability within these strains is useful to answer questions related to sex differences and disease progression in autoimmunity.
Several studies have examined the role of pregnancy factors such as hormones in mediating the immunosuppressive effects during EAE. Langer-Gould et al. (2002) reported a reduced incidence of EAE in SJL
